Notice of Funding Opportunity for Pre-clinical and Early Stage Clinical Development of Drug Candidates for Alzheimer's Disease
National Institutes of Health
Description
This grant provides funding for developing therapies, which includes activities like improving drug compounds (medicinal chemistry), studying how drugs are processed in the body (pharmacokinetics, absorption, distribution, metabolism, excretion), assessing safety (toxicology), testing effectiveness in animals, creating biomarkers to track treatment effects, and preparing drugs according to manufacturing standards. It also covers studies required to start human testing and initial Phase I cli…
Grant recipients will receive funding for therapy development activities, such as medicinal chemistry, pharmacokinetics, absorption, distribution, metabolism, excretion, toxicology, efficacy in animal models, development of biomarkers for target engagement, formulation development, chemical synt…
Source
Grant ID
PAR-25-297
Agency
National Institutes of Health
Subcategory/Subagency
National Institute on Aging
Key Dates
Opportunity Released
December 4, 2024
Eligibility
The following categories of applicants are invited to apply:
- Higher Education Institutions (Public/State-Controlled)
- Higher Education Institutions (Private)
- Nonprofits (Other than Institutions of Higher Education) with 501(c)(3) IRS status
- Nonprofits (Other than Institutions of Higher Education) without 501(c)(3) IRS status
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Local Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Eligible Agencies of the Federal Government
- U.S. Territories or Possessions
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
Awards & Funding
Award Ceiling
$1.5M
Funding Amount
~$1.5M
Similar opportunities
- Accelerating Innovative Drug and Device Therapies Translation from Discovery to Early Human Studies
National Institutes of Health
- Notice of Funding Opportunity (NOFO) for Preclinical Testing of Drugs for Alzheimer's Disease
National Institutes of Health
- Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institutes of Health
- Notice of Funding Opportunity for Alzheimer's Disease and Related Dementias Clinical Trials
National Institutes of Health
- Notice of Funding Opportunity for Rare Disease Therapeutic Development
National Institutes of Health